AMALGAMATED BANK - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$645
-10.8%
23,381
-2.8%
0.01%
-16.7%
Q2 2023$723
-10.2%
24,054
+8.2%
0.01%
-14.3%
Q1 2023$805
-6.2%
22,232
-7.6%
0.01%
-12.5%
Q4 2022$858
-99.9%
24,053
+1.8%
0.01%0.0%
Q3 2022$800,000
+18.0%
23,637
+0.8%
0.01%
+33.3%
Q2 2022$678,000
-10.3%
23,449
+0.3%
0.01%0.0%
Q1 2022$756,000
-47.2%
23,379
-52.4%
0.01%
+20.0%
Q4 2021$1,432,000
+113.7%
49,092
+95.3%
0.01%
-16.7%
Q3 2021$670,000
-15.1%
25,139
-1.9%
0.01%0.0%
Q2 2021$789,000
+255.4%
25,614
+173.1%
0.01%
+50.0%
Q4 2019$222,000
-12.9%
9,379
+1.3%
0.00%
-20.0%
Q3 2019$255,000
-17.7%
9,262
-1.0%
0.01%
-28.6%
Q2 2019$310,000
+11.9%
9,356
+18.5%
0.01%0.0%
Q1 2019$277,000
+8.2%
7,898
+2.3%
0.01%0.0%
Q4 2018$256,000
-46.6%
7,720
-3.6%
0.01%
-41.7%
Q2 2018$479,000
+49.7%
8,007
+14.7%
0.01%
+50.0%
Q1 2018$320,000
+13.5%
6,979
-1.5%
0.01%0.0%
Q4 2017$282,000
+7.6%
7,082
+8.3%
0.01%0.0%
Q3 2017$262,000
-7.7%
6,539
-0.6%
0.01%
-11.1%
Q2 2017$284,0006,5780.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders